Skip to main content

Table 1 Patient demographics and clinical characteristics of 125I seed implantation

From: Three-dimensional verification of 125I seed stability after permanent implantation in the parotid gland and periparotid region

Patient no.

Gender

Implant side

Age (ys)

Number of seeds

PD (Gy)

Seed activity (mCi)

Postoperative pathology

1

M

R

41

41

100

0.8

Mucoepidermoid carcinoma

2

M

R

52

30

120

0.8

Oncocytic carcinoma

3

M

L

46

51

100

0.8

Myoepithelial carcinoma

4

F

L

35

37

110

0.8

Mucoepidermoid carcinoma

5

F

L

60

32

120

0.8

Mucoepidermoid carcinoma

6

F

L

56

49

110

0.8

Mucoepidermoid carcinoma

7

F

L

43

58

120

0.7

Adenoid cystic carcinoma

8

F

L

55

55

120

0.7

Adenocarcinoma

9

F

R

22

52

120

0.7

Adenoid cystic carcinoma

10

M

L

46

49

100

0.7

Carcinoma in pleomorphic adenoma

11

F

R

46

37

110

0.6

Mucoepidermoid carcinoma

12

M

L

38

40

110

0.6

Carcinoma in pleomorphic adenoma

13

F

R

62

41

110

0.7

Adenocarcinoma

14

M

R

58

45

120

0.7

Adenoid cystic carcinoma

15

F

L

27

18

120

0.6

Acinic cell carcinoma

  1. Abbreviations: M male, F female, L left side, R right side, PD planned dose